跳至主要内容
临床试验/CTRI/2025/12/098290
CTRI/2025/12/098290尚未招募不适用

Urinary NGAL vs Serum Cystatin C vs KDIGO defined AKI for early diagnosis of AKI in less than 30 week Preterms. A Prospective Cohort study from tertiary care centre in eastern India

Neotia Bhagirathi Woman and Child Care Centre Newtown Kolkata1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2026年1月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
75
试验地点
1

研究概览

简要总结

Preterm babies are at high risk of acute kidney injury (AKI). Definition of AKI is not yet very clear in this group. Role early markers like NGAL and cystatin in comparison to current KDIGO criteria is not studied well. This study is amongst the very few and first to look at role of NGAL and Cystatin as early markers of acute renal injury in preterm infants and to compare them with currently use KDIGO criteria.

Purpose of he trial is to see how NGAL and cystatin compares with KDIGO criteria in early detection of AKI in preterm infants born before 30 weeks of gestation.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Day(s) 至 30.00 Day(s)(—)
性别
All

入选标准

  • All inborn preterm infants of gestational age less than and equal to 30 completed weeks who are admitted in NICU will be included.

排除标准

  • Congenital renal anomalies (e.g., renal dysplasia, multicystic dysplastic kidney, hydronephrosis [UTDA2 onward and decrease AF]): either antenatally diagnosed or diagnosed on day 1 ultrasound.
  • Genetic or metabolic disorders affecting kidney function (e.g., autosomal recessive polycystic kidney disease, congenital nephrotic syndrome).
  • Neonates with major congenital anomalies (e.g., cardiac defects, gastrointestinal malformations).
  • Neonates with chromosomal abnormalities (e.g., trisomy 21, trisomy 18, Turner syndrome).

研究者

发起方
Neotia Bhagirathi Woman and Child Care Centre Newtown Kolkata
申办方类型
Private hospital/clinic
责任方
Principal Investigator
主要研究者

Bismita Nath

Neotia Bhagirathi Woman and Child Care Centre

研究点 (1)

Loading locations...

相似试验